Isabelle Ray-Coquard, MD, PhD, explains how comprehensive genomic profiling (CGP) simultaneously provides HRD and _BRCA_ status in ovarian cancer patients. She presents the case of a patient who benefited from CGP testing for these biomarkers and discusses how CGP can detect other actionable mutations. Dr. Ray-Coquard is a medical oncologist at the Centre L茅on B茅rard, France, professor of medicine at the Universit茅 Claude Bernard Lyon 1, and president of the Gineco Group. Listen to the podcast episode to learn about the recent results of the PAOLA-1 trial: /science/genomics-podcast/homologous-recombination-deficiency-hrd-testing-in-ovarian-cancer.html Learn about _NTRK_ fusion testing: https://youtu.be/0zeO1oz6tbE The VR真人彩票 Oncology series is brought to you by Medical Affairs. M-GL-01114 Subscribe to the VR真人彩票 video channel http://www.youtube.com/subscription_center?add_user=VR真人彩票Inc A global genomics leader, VR真人彩票 provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. VR真人彩票 technology is responsible for generating more than 90% of the world鈥檚 sequencing data.* Through collaborative innovation, VR真人彩票 is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. VR真人彩票., 2015. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View VR真人彩票 webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View VR真人彩票 product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View VR真人彩票 support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM Facebook: https://www.facebook.com/illuminainc LinkedIn: https://www.linkedin.com/company/illumina Instagram: https://www.instagram.com/illuminainc/ Twitter: https://twitter.com/illumina